180
Participants
Start Date
February 7, 2025
Primary Completion Date
February 27, 2028
Study Completion Date
February 26, 2033
Remibrutinib (Blinded)
Remibrutinib (Blinded) active treatment
Placebo
Placebo
Remibrutinib (Open Label)
Remibrutinib (Open Label) active treatment
RECRUITING
Novartis Investigative Site, Kogarah
RECRUITING
Novartis Investigative Site, Leuven
RECRUITING
Novartis Investigative Site, Fitzroy
RECRUITING
Novartis Investigative Site, Southport
RECRUITING
Novartis Investigative Site, Taipei
RECRUITING
Dent Neurological Institute, Buffalo
RECRUITING
American Oncology Partners PA Center for Cancer & Blood Disorders, Bethesda
RECRUITING
Novartis Investigative Site, Lleida
RECRUITING
Novartis Investigative Site, Madrid
RECRUITING
Novartis Investigative Site, Málaga
RECRUITING
Novartis Investigative Site, Toulouse
RECRUITING
Advent Health Cancer Institute, Orlando
RECRUITING
Neurological Services of Orlando PA, Orlando
RECRUITING
Homestead Assoc In Research Inc, Homestead
RECRUITING
Novartis Investigative Site, Taoyuan District
RECRUITING
SFM Clinical Research LLC, Boca Raton
RECRUITING
Univ of Cincinnati Medical Center, Cincinnati
RECRUITING
Michigan State University-Department of Neurology, East Lansing
RECRUITING
Novartis Investigative Site, Busan
RECRUITING
Novartis Investigative Site, Tainan City
RECRUITING
Novartis Investigative Site, Paris
RECRUITING
Houston Methodist Hospital, Houston
RECRUITING
Novartis Investigative Site, Kaohsiung City
RECRUITING
Neuromuscular Research Center, Phoenix
RECRUITING
Honor Health Research Institute, Scottsdale
RECRUITING
University Of Southern California, Los Angeles
RECRUITING
Fullerton Neuro and Headache Ctr, Fullerton
RECRUITING
Univ Cali Irvine ALS Neuromuscular, Orange
RECRUITING
University of WA Division of Cardio, Seattle
RECRUITING
Novartis Investigative Site, Taipei
RECRUITING
Novartis Investigative Site, Ludhiana
RECRUITING
Novartis Investigative Site, Shanghai
RECRUITING
Novartis Investigative Site, Shanghai
RECRUITING
Novartis Investigative Site, Wuxi
RECRUITING
Novartis Investigative Site, Nashik
RECRUITING
Novartis Investigative Site, Brasov
RECRUITING
Novartis Investigative Site, Guangzhou
RECRUITING
Novartis Investigative Site, Sibiu
RECRUITING
Novartis Investigative Site, Chiba
RECRUITING
Center for Neurological Disorders G, Greenfield
RECRUITING
Novartis Investigative Site, London
RECRUITING
Novartis Investigative Site, Ottawa
RECRUITING
Novartis Investigative Site, Nice
RECRUITING
Novartis Investigative Site, Vellore
RECRUITING
Novartis Investigative Site, Fukushima
RECRUITING
Novartis Investigative Site, Sapporo
RECRUITING
Novartis Investigative Site, Sapporo
RECRUITING
Novartis Investigative Site, Nishinomiya
RECRUITING
Novartis Investigative Site, Hanamaki
RECRUITING
Novartis Investigative Site, Sendai
RECRUITING
Novartis Investigative Site, Suita
RECRUITING
Novartis Investigative Site, Higashi-Matsuyama
RECRUITING
Novartis Investigative Site, Koshigaya
RECRUITING
Novartis Investigative Site, Shinjuku Ku
RECRUITING
Novartis Investigative Site, Hiroshima
RECRUITING
Novartis Investigative Site, Bydgoszcz
RECRUITING
Novartis Investigative Site, Katowice
RECRUITING
Novartis Investigative Site, Warsaw
RECRUITING
Novartis Investigative Site, Warsaw
RECRUITING
Novartis Investigative Site, Bucharest
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, Seoul
RECRUITING
Novartis Investigative Site, L'Hospitalet de Llobregat
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY